Literature DB >> 2414911

The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies.

M T Berton, R G Webster.   

Abstract

We have probed the antigenic structure of the influenza B virus hemagglutinin (HA) with monoclonal antibodies specific for the HA of influenza B virus, B/Oregon/5/80. Seventeen laboratory-selected antigenic variants of this virus were analyzed by hemagglutination-inhibition (HI) assays or ELISA and an operational antigenic map was constructed. In addition, the monoclonal antibodies were tested in a competitive binding assay to construct a topological map of the antigenic sites. In contrast to the influenza A virus HA, only a single immunodominant antigenic site composed of several overlapping clusters of epitopes was defined by the HI-positive antibodies. Three variants could be distinguished from the parental virus with polyclonal antisera by HI and infectivity reduction assays suggesting that changes in this antigenic site may be sufficient to provide an epidemiological advantage to influenza B viruses in nature. In addition, two nonoverlapping epitopes of unknown biological significance were identified in the competitive binding analysis by two monoclonal antibodies with no HI activity and little or no neutralizing activity. We previously identified single amino acid substitutions in the HAs of the antigenic variants used in this study (M. T. Berton, C. W. Naeve, and R. G. Webster (1984), J. Virol. 52, 919-927). These changes occurred in regions of the molecule which, by amino acid sequence alignment, appeared to correspond to proposed antigenic sites A and B on the H3 HA of influenza A virus. Correlation with the antigenic map established in this report, however, demonstrates that the amino acid residues actually contribute to a single antigenic site on the influenza B virus HA and suggests significant differences in the antigenic structures of the influenza A and B virus HAs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414911     DOI: 10.1016/0042-6822(85)90396-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature.

Authors:  J A McCullers; G C Wang; S He; R G Webster
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Québec, Canada, during the 1998-2001 period.

Authors:  Yacine Abed; Michael B Coulthart; Yan Li; Guy Boivin
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

3.  Evolution of the hemagglutinin gene of influenza B virus was driven by both positive and negative selection pressures.

Authors:  S Zou; I Prud'homme; J M Weber
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Evolutionary changes in influenza B are not primarily governed by antibody selection.

Authors:  G M Air; A J Gibbs; W G Laver; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination.

Authors:  Rodrigo B Abreu; Greg A Kirchenbaum; Emily F Clutter; Giuseppe A Sautto; Ted M Ross
Journal:  JCI Insight       Date:  2020-01-16

6.  Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987-91.

Authors:  M L Hemphill; P A Rota; V T Ivanova; A N Slepushkin; A P Kendal
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

7.  Structural basis for the divergent evolution of influenza B virus hemagglutinin.

Authors:  Fengyun Ni; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-08-27       Impact factor: 3.616

8.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

9.  Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

Authors:  B Sherry; A G Mosser; R J Colonno; R R Rueckert
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.

Authors:  Robert E Sealy; Bart G Jones; Sherri L Surman; Kristen Branum; Nanna M Howlett; Patricia M Flynn; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2015-11-06       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.